H-1B sponsorship profile: Eikon Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Eikon Therapeutics, Inc filed 43 Labor Condition Applications covering 43 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (43 certified of 43 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Eikon Therapeutics, Inc’s H-1B petitions range from $76,461 at the low end to $273,770 at the high end, with a petition-weighted average of $145,279. That range reflects the mix of occupations the company sponsors, led by Senior Informatics Engineer (3 petitions at $174,269 avg), followed by Software Engineer and Scientist, Cell Biology. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Eikon Therapeutics, Inc is headquartered in Hayward, CA under NAICS code 541714, and places H-1B workers across 5 states, most heavily in CA, NJ, NY. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Eikon Therapeutics, Inc ranks. By H-1B petition volume, Eikon Therapeutics, Inc is #5,367 of 119,880 employers nationally and #781 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.